Clinical Trial Update: Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical study of Diazoxide Choline Controlled-Release Tablet (DCCR) for Prader-Willi syndrome has completed (status: COMPLETED); sponsor Essent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Diazoxide Choline Controlled-Release Tablet (diazoxide choline controlled-release tablet)

Snippet

Sponsor: Essentialis, Inc. | Conditions: Prader-Willi Syndrome | Phase 1, Phase 2 | Status: COMPLETED